A Nationwide Analysis Evaluating the Safety of Using Acellular Dermal Matrix with Tissue Expander-Based Breast Reconstruction

Background In March 2021, the United States Food and Drug Administration (FDA) safety communication cautioned against the use of acellular dermal matrix (ADM) products in breast reconstruction and reiterated that the FDA does not approve ADM use in breast surgery. This study aims to assess the safet...

Full description

Bibliographic Details

Published in:	Archives of Plastic Surgery
Main Authors:	Jessica Luo, Whitney D. Moss, Giovanna R. Pires, Irfan A. Rhemtulla, Megan Rosales, Gregory J. Stoddard, Jayant P. Agarwal, Alvin C. Kwok
Format:	Article
Language:	English
Published:	Thieme Medical Publishers, Inc. 2022-11-01
Subjects:	tissue expander breast reconstruction outcomes acellular dermal matrix
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1758638